Raymond James Financial Services Advisors, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$204,593
-40.4%
7,872
-34.4%
0.00%
-100.0%
Q1 2024$343,143
-2.4%
11,998
+4.5%
0.00%0.0%
Q4 2023$351,410
-39.0%
11,484
-46.5%
0.00%0.0%
Q3 2023$576,442
-26.6%
21,453
-2.6%
0.00%0.0%
Q2 2023$785,625
+87.2%
22,031
+33.4%
0.00%0.0%
Q1 2023$419,633
-43.7%
16,521
-10.1%
0.00%0.0%
Q4 2022$744,966
+16.2%
18,367
-5.2%
0.00%0.0%
Q3 2022$641,000
-3.6%
19,382
+2.7%
0.00%0.0%
Q2 2022$665,000
-77.8%
18,876
-71.0%
0.00%
-83.3%
Q1 2022$2,995,000
+28.1%
65,132
+84.7%
0.01%
+50.0%
Q4 2021$2,338,000
+16.4%
35,269
+9.6%
0.00%0.0%
Q3 2021$2,009,000
+1.9%
32,186
+35.2%
0.00%0.0%
Q2 2021$1,972,000
+53.9%
23,813
+23.3%
0.00%
+33.3%
Q1 2021$1,281,000
-18.9%
19,312
-6.2%
0.00%
-25.0%
Q4 2020$1,580,000
+22.2%
20,587
-31.4%
0.00%0.0%
Q3 2020$1,293,000
-12.8%
30,027
-12.5%
0.00%
-20.0%
Q2 2020$1,483,000
+39.0%
34,335
-7.5%
0.01%0.0%
Q1 2020$1,067,000
-58.1%
37,104
-7.5%
0.01%
-37.5%
Q4 2019$2,544,000
+208.0%
40,107
+36.9%
0.01%
+166.7%
Q3 2019$826,000
+895.2%
29,298
+154.1%
0.00%
Q1 2018$83,00011,5320.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders